[18F]FDDNP PET binding predicts change in executive function in a pilot clinical trial of geriatric depression.

Beatrix KrausePrabha SiddarthKelsey T LairdLinda ErcoliKatherine NarrJorge R BarrioGary SmallHelen Lavretsky

Published in: International psychogeriatrics (2020)

[18F]FDDNP binding may predict cognitive response to antidepressant treatment. Larger trials are required to further test the value of [18F]FDDNP binding as a biomarker for cognitive improvement with antidepressant treatment in geriatric depression.

Keyphrases

clinical trial
major depressive disorder
depressive symptoms
computed tomography
bipolar disorder